Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.

Oncotarget - 28 Mar 2017

Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ning

Abstract excerpt

Although KRAS and TP53 mutations are common in both inflammatory bowel disease-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (S-CRC), molecular events leading to carcinogenesis may be different. Previous studies comparing the frequency of KRAS and TP53 mutations in IBD-CRC and S-CRC were inconsistent. We performed a meta-analysis to compare the presence of KRAS and TP53 mutations among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to KRAS gene
Share to Inflammatory Bowel Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Share to Risk Factors

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 28077799
DOI: 10.18632/oncotarget.14549
PMCID: PMC5400656

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.PMID 28077799Read ↗

Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.Semantic proximity Read ↗

The Association of KRAS and P53 Gene Mutations and MDM2 Expression with the Occurrence of Colorectal Cancer.Semantic proximity Read ↗

Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products.Semantic proximity Read ↗

Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.Semantic proximity Read ↗

Colorectal cancer in patients with inflammatory bowel disease.Semantic proximity Read ↗

Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.Semantic proximity Read ↗

Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps.Semantic proximity Read ↗

Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.Semantic proximity Read ↗

Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas.Semantic proximity Read ↗

Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.Semantic proximity Read ↗

IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic AdenomasSemantic proximity Read ↗

KRAS mutations in colorectal cancer from Tunisia: relationships with clinicopathologic variables and data on TP53 mutations and microsatellite instability.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.